SKYE VALEN: Open Payments
NPI 1447907282 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 6 payments from 5 companies in 2025. Trend: 2023 $27 · 2024 $0 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $42 |
| UCB, Inc. | 1 | $30 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $25 |
| Invivyd Inc | 1 | $21 |
Products named: TREMFYA, Bimzelx, LUPKYNIS, Gazyva, PEMGARDA.
Industry payments across WI — which companies pay providers there.
